March, 2023
Read More
Women’s Health Diagnostics - Market Report Highlights, 2021
Women’s Health Diagnostics Market Size Outlook
Women’s Health Diagnostics Market Analysis, 2021
Growing awareness about various health disorders, increasing prevalence of chronic conditions, ageing and changing lifestyles are encouraging companies to develop testing and diagnostic solutions across the women’s healthcare sphere. Companies like Siemens, Abbott, Roche and others are focusing on constantly widening their product portfolio across wide disease states and conditions that impact women.
Diagnostic services play a vital role in spotting health problems in women and providing information of required medical interventions well in advance. Ageing populations and changing lifestyles are among the main factors promoting health-related disorders and increasing awareness of these conditions among women are main market drivers. As early diagnosis boosts possibility of positive outcomes and can lower further treatment costs, an increasing drive towards diagnostics in women’s health market is being observed. Significant improvement in healthcare infrastructures across developing countries like China, India, Brazil and others coupled with growth in immunoassay diagnostic techniques offer significant market potential.
The global women’s health diagnostics market is valued at $24.1 billion in 2020. Further, over the forecast period to 2028, the market is poised to register 8.41% growth (Compounded Annual Growth Rate- CAGR) to reach $45.9 Billion in 2028. The major factors shaping up the demand outlook include increasing incidences of infectious diseases, increasing adoption of fertility and gynaecologic testing, widening investments in new diagnostic centres and widening portfolio of solutions offered by companies. On the other hand, the penetration rate of the laboratory and point of care diagnostics across several developing countries remains low due to low awareness, limited affordability, lack of skilled personnel and poor accessibility in addition to low reimbursement rates for diagnostics.
Women’s health diagnostics market encompasses laboratory and point-of-care (POC) testing that are particular to women. Over the near to medium term future, the market demand for POC testing is estimated to grow significantly due to increasing prevalence of chronic and lifestyle disorders, infectious disease and new product launches in the category.
Among developing countries, initiatives by NGOs and governments to create awareness of precautionary measures, testing options and their advantages is encouraging market growth. Increasing diseases and infections related to women require specific healthcare facilities and accordingly, investments from both public and private sectors continue to increase in the sector. Further, an increasing trend towards development of medium to large scale diagnostic and imaging centres in public-private-partnership (PPP) models is being observed.
The report analyses the global women’s health diagnostics market across applications, end user verticals and geographies. Of these, the applications include Breast cancer testing, Infectious disease testing, STD testing, cervical and ovarian testing, osteoporosis, gynaecology, and fertility diagnostics. Among applications, breast cancer testing remain the dominant application type with 20.7% market share, driven largely by increasing prevalence, and growing awareness.
In terms of end users, the market is categorized into hospitals and clinics, diagnostic and imaging centres and homecare testing markets. Of these, hospitals and clinics remains the dominant end user market with 75.8% market share. Improved living standards, inflow of patients and expanding healthcare infrastructure are the main market drivers in the segment.
High awareness and affordability of diagnostics, large scale point-of-care diagnostics coupled with increasing chronic and lifestyle disorders are the main market drivers for women’s health diagnostics in developed countries in North America, and Europe. Among regions, North America remained the global markets with the US being the world’s largest country for diagnostics. The region accounted for 41.3% of global market demand, followed by Europe (27.3%). On the other hand, Asia Pacific is the fastest growing geography, forecast to register 10.97% CAGR over the forecast period. The fastest growth in China, India, South Korea, Brazil, Russia and other countries is driven by epidemiological shift from infectious diseases to chronic diseases and increasing affordability coupled with widening product portfolio and PPP partnership model based investments in diagnostics infrastructure.
The global women’s health diagnostics market is characterized by the presence of diverse international and regional players. Among companies, Abbott Laboratories, F. Hoffmann-La Roche, Hologic Inc., Siemens AG, Cardinal Health, General Electric, Quest Diagnostics Inc., Koninklijke Philips and others are among the leading companies in the industry. With growing regulatory approvals for immunoassay diagnostic techniques, and high prevalence of infectious diseases, the companies are widening their portfolio of solutions. However, intense competitive conditions make companies capable of delivering value in under-pressure market conditions tend to excel in the industry.
Women’s Health Diagnostics Market Trends- Private diagnostic and imaging centres hold the key for future
Significant market potential for imaging procedures and advanced diagnostic systems in women is encouraging continuous investments in private diagnostic centres. Further, most small and medium size hospitals and clinics rely on private diagnostics for testing their patients. Across markets, continuous chain of hospitals across cities are being developed.
Further, availability of private centres will lead to increased number of increased procedures, which will strengthen the demand for diagnostics of women’s health-related disorders. However, availability of skilled personnel in developing countries remains main challenge for expanding into developing countries.
On the other hand, governments in developing countries are also strengthening diagnostic testing capabilities through partnerships with private companies. Public hospitals are also partnering with other companies to build centres of imaging, radiation, and other diagnostic systems. Successful public-private partnership can extend the reach of health facilities, which will strengthen market potential. In particular, the model is quickly gaining prominence from India, China, Brazil, African markets and other countries.
Women’s Health Diagnostics Market Challenges- Lack of trained personnel pose market expansion challenges
Despite increasing patients and awareness towards early diagnosis, the lab technicians and doctors required for handling the technology are inadequate in most markets. Development of advanced systems also requires skilled and trained personnel to operate these systems. However, China, Eastern Europe and other countries face skill gap in pathologists and laboratory technicians, which lowers the penetration of advanced systems into these markets. Both companies and hospitals are focusing on extending intense training to fill the skill gap across markets.
Women’s Health Diagnostics Market Companies Profiled in the Report-
Global infectious disease diagnostic testing market Outlook
The global infectious disease diagnostic testing market was valued at $3.7 billion in 2020 and is expected to reach $6.5 billion by 2028, growing at a CAGR of 7.1%. Roche Diagnostics, Quest Diagnostics, Hologic, Abbott Laboratories, Ortho Clinical Diagnostics, and bioMerieux are among the key players in the segment.
Molecular diagnostic techniques such as hybridization, PCR, DNA sequencing, next generation sequencing, and mass spectroscopy and Point of Care based on antibody or microbial particle are used.
Urinary tract infections (UTIs) are common in females and accounts for more than 6 million visits to physicians per year in the US. The increasing prevalence of UTIs is one of the main market drivers for growth in the market segment. Rising prevalence of diabetes, hospital acquired infections and others are main drivers of UTIs in women. Accordingly, companies are increasingly marketing urine test kits to diagnose infections in urine at homes. Further, electrochemical analysis tools are also witnessing significant demand growth worldwide.
In addition to UTIs, Hepatitis B and Hepatitis C are also largely observed among women. In situ hybridization and PCR assays are among the most popular diagnosis tools in the segment. Further, point of care testing is also witnessing increased demand in the segment. Tuberculosis, Methicillin-resistant Staphylococcus Aureus (MRSA) infection caused by Staphylococcus (staph) bacteria, Streptococcal infections caused by the group of bacteria Streptococcus and others are among the leading conditions in women’s health diagnostics market.
Women’s Health Diagnostics Market Segmentation
1. Executive Summary
1.1 Introduction to Women’s Health Diagnostics Markets
1.2 Women’s Health Diagnostics Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in the Women’s Health Diagnostics Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Women’s Health Diagnostics Market Trends
3.1.1 Increasing global Healthcare Expenditure worldwide supports Diagnostics Spending
3.1.2 Homecare monitoring and diagnostics market growth presents potential opportunities
3.1.3 Refurbished diagnostic systems present significant market potential
3.1.4 Private diagnostic and imaging centers hold the key to future
3.2 Key Women’s Health Diagnostics Market Growth Drivers
3.2.1 Increasing prevalence of diseases among women support future market growth
3.2.2 Huge market potential from emerging economies
3.3 Key Women’s Health Diagnostics Market Growth Restraints
3.3.1 Lack of trained personnel in emerging markets
3.3.2 High cost of diagnostic imaging systems and procedures
4 Women’s Health Diagnostics Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts: Women’s Health Diagnostics Market Size Outlook to 2030
4.2 Reference Growth Case Scenario Forecasts: Women’s Health Diagnostics Market Size Outlook to 2030
4.3 High Growth Case Scenario Forecasts: Women’s Health Diagnostics Market Size Outlook to 2030
5. Women’s Health Diagnostics Market Segmentation- Outlook by Type
5.1 Women’s Health Diagnostics Market Share Analysis by Type, 2023
5.2 Breast Cancer Diagnostics Market Outlook to 2030
5.3 Women’s Infectious Disease Testing Market Outlook to 2030
5.4 Women’s STI Testing Market Outlook to 2030
5.5 Cervical and Ovarian Cancer Diagnostics Market Outlook to 2030
5.6 Osteoporosis Testing Market Outlook to 2030
5.7 Prenatal Genetic Screening Market Outlook to 2030
5.8 Pregnancy and Fertility Diagnosis Market Outlook to 2030
5.9 Other Women’s Health Diagnostics Market Outlook to 2030
7. Women’s Health Diagnostics Market Segmentation- Outlook by End-Use Industry
7.1 Women’s Health Diagnostics Market Share Analysis by End-Use Industry, 2023
7.2 Hospitals and Clinics: Women’s Health Diagnostics Market Revenue Outlook to 2030
7.3 Diagnostic and Imaging Centers: Women’s Health Diagnostics Market Revenue Outlook to 2030
7.4 Home Care: Women’s Health Diagnostics Market Revenue Outlook to 2030
8. North America Women’s Health Diagnostics Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Women’s Health Diagnostics Market Growth Opportunities
8.2.1 North America Women’s Health Diagnostics Market Outlook by Type, 2021 to 2030
8.2.3 North America Women’s Health Diagnostics Market Outlook by End-User Industry, 2021 to 2030
8.2.4 North America Women’s Health Diagnostics Market Outlook by Country, 2021 to 2030
8.3 United States Women’s Health Diagnostics Market Outlook, 2021 to 2030
8.4 Canada Women’s Health Diagnostics Market Outlook, 2021 to 2030
8.5 Mexico Women’s Health Diagnostics Market Outlook, 2021 to 2030
9. Europe Women’s Health Diagnostics Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Women’s Health Diagnostics Market Growth Opportunities
9.2.1 Europe Women’s Health Diagnostics Market Outlook by Type, 2021 to 2030
9.2.3 Europe Women’s Health Diagnostics Market Outlook by End-User Industry, 2021 to 2030
9.2.4 Europe Women’s Health Diagnostics Market Outlook by Country, 2021 to 2030
9.3 Germany Women’s Health Diagnostics Market Outlook, 2021 to 2030
9.4 France Women’s Health Diagnostics Market Outlook, 2021 to 2030
9.5 United Kingdom Women’s Health Diagnostics Market Outlook, 2021 to 2030
9.6 Spain Women’s Health Diagnostics Market Outlook, 2021 to 2030
9.7 Italy Women’s Health Diagnostics Market Outlook, 2021 to 2030
9.8 Other Europe Women’s Health Diagnostics Market Outlook, 2021 to 2030
10. Asia Pacific Women’s Health Diagnostics Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Women’s Health Diagnostics Market Growth Opportunities
10.2.1 Asia Pacific Women’s Health Diagnostics Market Outlook by Type, 2021 to 2030
10.2.3 Asia Pacific Women’s Health Diagnostics Market Outlook by End-User Industry, 2021 to 2030
10.2.4 Asia Pacific Women’s Health Diagnostics Market Outlook by Country, 2021 to 2030
10.3 China Women’s Health Diagnostics Market Outlook, 2021 to 2030
10.4 Japan Women’s Health Diagnostics Market Outlook, 2021 to 2030
10.5 India Women’s Health Diagnostics Market Outlook, 2021 to 2030
10.6 South Korea Women’s Health Diagnostics Market Outlook, 2021 to 2030
10.7 Indonesia Women’s Health Diagnostics Market Outlook, 2021 to 2030
10.8 Other Asia Pacific Women’s Health Diagnostics Market Outlook, 2021 to 2030
11. South and Central America Women’s Health Diagnostics Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 South and Central America Women’s Health Diagnostics Market Growth Opportunities
11.2.1 South and Central America Women’s Health Diagnostics Market Outlook by Type, 2021 to 2030
11.2.3 South and Central America Women’s Health Diagnostics Market Outlook by End-User Industry, 2021 to 2030
11.2.4 South and Central America Women’s Health Diagnostics Market Outlook by Country, 2021 to 2030
11.3 Brazil Women’s Health Diagnostics Market Outlook, 2021 to 2030
11.4 Argentina Women’s Health Diagnostics Market Outlook, 2021 to 2030
11.5 Other Latin America Women’s Health Diagnostics Market Outlook, 2021 to 2030
12. Middle East and Africa Women’s Health Diagnostics Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and Africa Women’s Health Diagnostics Market Growth Opportunities
12.2.1 Middle East and Africa Women’s Health Diagnostics Market Outlook by Type, 2021 to 2030
12.2.3 Middle East and Africa Women’s Health Diagnostics Market Outlook by End-User Industry, 2021 to 2030
12.2.4 Middle East and Africa Women’s Health Diagnostics Market Outlook by Country, 2021 to 2030
12.3 Saudi Arabia Women’s Health Diagnostics Market Outlook, 2021 to 2030
12.4 United Arab Emirates (the UAE) Women’s Health Diagnostics Market Outlook, 2021 to 2030
12.5 Other Middle East Women’s Health Diagnostics Market Outlook, 2021 to 2030
12.6 Egypt Women’s Health Diagnostics Market Outlook, 2021 to 2030
12.7 South Africa Women’s Health Diagnostics Market Outlook, 2021 to 2030
12.8 Other Africa Women’s Health Diagnostics Market Outlook, 2021 to 2030
13. Profiles of major world Women’s Health Diagnostics Companies
13.1 F. Hoffmann-La Roche Ltd
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.2 Hologic, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.3 Quest Diagnostics Incorporated
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.4 Abbott Laboratories
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.5 Becton, Dickinson, and Company
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.6 Siemens AG
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.7 Cardinal Health, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.8 General Electric Company
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
Increasing prevalence of diseases among women supports future market growth, Huge market potential from emerging economies, Increasing global Healthcare Expenditure worldwide supports Diagnostics Spending, Homecare monitoring and diagnostics market growth presents potential opportunities, Refurbished diagnostic systems present significant market potential, Private diagnostic and imaging centers hold the key to future
Leading women's health diagnostics companies analyzed in the report are F. Hoffmann-La Roche Ltd., Hologic, Inc., Quest Diagnostics Inc, Abbott Laboratories, Siemens AG, Cardinal Health, Becton, Dickinson and Company, General Electric Company
Breast Cancer Diagnostics is the dominant market segment. The report analyzes the women's health diagnostics across Breast Cancer Diagnostics, Infectious Disease Testing, STI Testing, Cervical and Ovarian Cancer Diagnostics, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy and Fertility Diagnosis, and Other Diagnostics